ALung Technologies raises another $10 million for its Hemolung respiratory assist device.
ALung Technologies said it drummed up another $10 million it plans to use to continue commercializing its Hemolung respiratory assist device.
Pittsburgh-based ALung's Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient's blood via a small catheter inserted into the jugular or femoral vein.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1izu5gG
Cap comentari:
Publica un comentari a l'entrada